A double-blind, placebo-controlled study found that PEMF therapy may significantly reduce pain and narcotic use after breast augmentation surgery. Patients who received PEMF reported 57% lower pain at 1 hour, 300% lower pain at 5 hours, and 2.2× less narcotic use — without any side effects. These results suggest PEMF could be a safe, noninvasive tool for improving recovery outcomes.
This double-blind, placebo-controlled study explored whether Pulsed Electromagnetic Field (PEMF) therapy could reduce pain after breast augmentation surgery. The results were promising: patients who used PEMF therapy after surgery reported significantly less pain, as measured by a standardized pain scale, compared to those who used a sham device. The therapy was noninvasive, easy to use, and free of side effects—making it a compelling recovery option for post-surgical care.
Study Overview
Title: Reduction of Postoperative Pain with Pulsed Electromagnetic Field Therapy: A Double-Blind, Placebo-Controlled Study
Quick Summary: This clinical study evaluated the effectiveness of PEMF therapy in managing pain after breast augmentation. Thirty-eight female patients were randomly assigned to either active PEMF treatment or a placebo (sham) device. The study found that those in the PEMF group experienced significantly lower pain scores, suggesting PEMF may be a valuable adjunct to post-surgical care.
Key Findings:
Pain Reduction:
57% lower pain scores at 1 hour post-op
300% lower pain scores at 5 hours post-op
Pain relief persisted up to 48 hours after surgery in the PEMF group
Medication Use:
2.2× reduction in narcotic use among PEMF-treated patients
Inflammation Marker:
275% lower IL-1β concentration in wound fluid at 24 hours
No significant changes in TNF-α, VEGF, or FGF-2
Safety:
No adverse effects were reported in either group
Study Details:
Sample Size: 38 women undergoing breast augmentation
Study Design: Prospective, randomized, double-blind, placebo-controlled
Treatment Protocol: Patients received either active PEMF therapy or a sham device post-surgery
Assessment Period: Pain scores monitored at multiple intervals postoperatively
Key Outcome Measures: Pain intensity (visual analogue scale); patient safety
Statistical Results: Significant reduction in pain in the PEMF group (p-value not specified in abstract)
Year Published: 2010
Where Published: Aesthetic Plastic Surgery
Learn More
You can read the abstract on PubMed here.
—
BH Labs Recovery Pods package these clinically-studied modalities into one turnkey system — starting at $49K.
Talk to Us